Topics

FDA, EU Investigating Probable Carcinogen in Heartburn Meds

09:52 EDT 13 Sep 2019 | Medscape

Drug regulators in the US and Europe find the probable carcinogen NDMA in heartburn medicines containing ranitidine, reminiscent of the 'sartan' contamination saga.
News Alerts

Original Article: FDA, EU Investigating Probable Carcinogen in Heartburn Meds

NEXT ARTICLE

More From BioPortfolio on "FDA, EU Investigating Probable Carcinogen in Heartburn Meds"

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Food
Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...